A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
BioDefense Pro is a Cambridge-based biotechnology company operating in the biodefense and biosecurity sector. Based on its name and location in the prominent biotech hub of Cambridge, the company likely focuses on developing countermeasures against biological threats, which could include vaccines, therapeutics, or diagnostic tools for biodefense applications.
The company has raised $11 million in seed funding, indicating it is in the early stages of development but has attracted initial investor interest in its biodefense technologies. The biodefense market has seen increased attention from both government and private investors, particularly given growing concerns about biological threats and pandemic preparedness. As an active company in this critical sector, BioDefense Pro appears positioned to address national security and public health challenges through biotechnology solutions.
| Date | Round | Amount | Lead Investor |
|---|---|---|---|
| Feb 2026 | Seed | $11M | RA Capital Management |
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
BioDefense Pro has raised $11M in total funding, with their most recent round being a Seed. The company operates in the Biotech sector.
BioDefense Pro operates in the Biotech sector. A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
